Study to improve dEployment related Asthma by using L-citrulline Supplementation (SEALS)
Primary Objective
1. Determine if L-citrulline supplementation improves deployment related asthma control and increases FeNO (co-primary outcomes). Subjects will receive either 15 g L-citrulline/day or matched placebo for 7 weeks followed by a 4-6 week washout and then 7 weeks of the opposite treatment.
Description
2. This is a proof-of-concept, randomized, double blinded, placebo controlled study to determine if adding on L-citrulline for deployment related asthmatics: a) improves asthma control, and b) increases FeNO levels.
Details
Locations
Outpatient CTRC
Rocky Mountain Regional VA Medical Center
University of Colorado Hospital
Principal Investigator
Fernando Holguin
Study ID
Protocol Number: 21-2804
More information available at ClinicalTrials.gov: NCT05259904
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers